Heart Disease News and Research

Latest Heart Disease News and Research

Low walkability in neighborhoods associated with higher heart disease risk

Low neighborhood walkability is associated with increased risk of cardiovascular disease (CVD), according to research presented today at ESC Preventive Cardiology 2025, a scientific congress of the European Society of Cardiology (ESC).

3 Apr 2025

Heart failure linked to faster cognitive decline

There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier in life, a study suggests.

3 Apr 2025

Dutch dietary guidelines could dramatically cut chronic disease rates by 2050

Researchers investigate the impact of current Dutch dietary guidelines on non-communicable disease rates.

3 Apr 2025

Experts develop new guidelines for the treatment of schizophrenia

New guidelines have been developed for the treatment of schizophrenia after a collaboration of international experts from 30 countries.

2 Apr 2025

National Walking Day encourages movement for better health

Sedentary behavior has become a national health crisis, with 1 in 4 U.S. adults sitting for more than eight hours a day, increasing their risk for heart disease, stroke, and mental health challenges, according to the Centers for Disease Control and Prevention.

2 Apr 2025

Study reveals hidden cardiovascular risks in real-world low-carb diets

Researchers examined a real-world low-carbohydrate high-fat (LCHF) diet population to assess links between nutrient intake and cardiovascular risk.

2 Apr 2025

Blood pressure trajectories during early pregnancy can stratify future hypertension risk

NIH-supported study reveals new risk group for future high blood pressure, heart disease.

2 Apr 2025

Transformative potential of AI to enhance coronary heart disease detection

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Coronary heart disease (CHD), the most common cause of mortality globally, poses a formidable challenge to modern healthcare systems.

2 Apr 2025

Weekend exercise can offer the same health benefits as daily workouts

Being physically active for one to two days a week, often called a "weekend warrior," may provide comparable health and life-prolonging benefits as smaller doses of daily physical activity if the physical effort is moderate to vigorous and totals 150 minutes a week in line with recommended guidelines for weekly physical activity, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

2 Apr 2025

How much will that surgery cost? 🤷 Hospital prices remain largely unhelpful.

It's a holy grail of health care: forcing the industry to reveal prices negotiated between health plans and hospitals — information that had long been treated as a trade secret.

2 Apr 2025

Rural communities face higher rates of heart disease and risk factors

A research team funded by the National Institutes of Health (NIH) uncovered higher rates of heart disease and worse heart health affecting adults living in rural communities compared to urban areas and the factors that likely drive these differences.

1 Apr 2025

Virtual diabetes self-management interventions improve blood sugar levels

Relatively inexpensive and accessible self-management interventions to help people manage Type 2 diabetes have been found to significantly reduce the blood sugar marker used to diagnose and manage the disease.

1 Apr 2025

Survey shows increased awareness of alcohol’s cancer risks

Public awareness of the link between drinking alcohol and an elevated risk of cancer has grown since last fall, with more than half of Americans now saying that regularly consuming alcohol increases your chances of later developing cancer, according to a survey by the Annenberg Public Policy Center (APPC) of the University of Pennsylvania.

1 Apr 2025

Only 13% of French adults have optimal heart health—here’s what’s driving the gap

Only 13% of French adults aged 18–69 have optimal cardiovascular health, according to a national study using the American Heart Association’s Life’s Essential 8 (LE8) score. The findings highlight missed prevention opportunities and suggest that modest lifestyle changes could prevent up to 81% of cardiovascular events.

1 Apr 2025

Compound heatwaves linked to increased cardiac deaths

Cardiac deaths increase significantly during compound heatwaves-heatwaves where temperatures are elevated both during the day and overnight-according to a new study in JACC, the flagship journal of the American College of Cardiology.

1 Apr 2025

NYC and Baltimore scientists awarded grants for cardiovascular and diabetes research

A New York City-based physician scientist who explores ways to improve health by looking at the ways in which cells and molecules impact disease and an epidemiologist from Baltimore who has devoted her career to identifying ways to improve screening, diagnosis and patient care for people with diabetes are the most recent American Heart Association Merit Award recipients.

1 Apr 2025

The evolution of OCT for retinal imaging and disease intervention

Dr. Yifan Jian explores the evolution of OCT, challenges in retinal imaging, and AI's potential in biophotonics, shaping the future of ophthalmic diagnostics.

From Avantier Inc. 1 Apr 2025

WINREVAIR™ (sotatercept-csrk) reduced the risk of a composite of all-cause death, lung transplantation and hospitalization for pulmonary arterial hypertension (PAH) by 76% compared to placebo in the phase 3 ZENITH trial

Merck, known as MSD outside of the United States and Canada, today announced the first presentation of results from the Phase 3 ZENITH trial evaluating WINREVAIR™ (sotatercept-csrk) compared to placebo in adults with pulmonary arterial hypertension (PAH, Group 1 PH) WHO* functional class (FC) III or IV at high risk of mortality who were on maximum tolerated background PAH therapy. At a median follow-up of 10.6 months (range, 0.3-26.1), WINREVAIR reduced the relative risk of major morbidity and mortality events (the composite of all-cause death, lung transplantation and PAH worsening-related hospitalization of ≥24 hours) by 76% (HR=0.24 [95% CI, 0.13-0.43]; p<0.0001 [1-sided]) compared to placebo.

1 Apr 2025

Novo Nordisk A/S: Rybelsus® (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025

Novo Nordisk today presented the full results from the SOUL cardiovascular outcomes trial, demonstrating that Rybelsus® (oral semaglutide) significantly reduced the risk of major adverse cardiovascular events in adults with type 2 diabetes and cardiovascular disease (CVD) and/or chronic kidney disease (CKD).

1 Apr 2025

Study shows women can hear better than men

An international team of scientists has found that biological sex is the leading factor explaining differences in hearing sensitivity, with women having significantly more sensitive hearing than men.

From University of Bath 1 Apr 2025